In other cases, blood levels of GM-CSF [73] and M-CSF [74] were significantly heightened in severe COVID-19 patients and a combinatorial treatment of HSPCs with IL-6, GM-CSF, and M-CSF enhanced the generation of MDSC-like cells [72]. This evidence concerns the gene CSF1 and COVID-19.